Use of antiglaucoma preparations and miotics

H7_GLAUCOMAMEDICATION

glaucoma: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — S01EA 1 out of 7 registries used, show all original rules.	3209
4. Check minimum number of events Min. number of events 3	3209
5. Include endpoints None	3209
6. Filter based on genotype QC (FinnGen only)	3209

Control definitions (FinnGen only)

Control exclude: H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	H7_GLAUCOMAMEDICATION
CONTROL_EXCLUDE	H7_GLAUCOMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	S01EA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of antiglaucoma preparations and miotics based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31315	19313	11757
Only index persons	26241	16426	9815
Unadjusted period prevalence (%)
Whole population	0.47	0.55	0.33
Only index persons	0.52	0.60	0.37
Median age at first event (years)
Whole population	71.87	73.07	69.86
Only index persons	70.67	71.97	68.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3209	1746	1463
Unadjusted period prevalence (%)	0.62	0.60	0.64
Median age at first event (years)	67.67	67.28	68.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2864: Matched controls
28638

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S01ED01

ATC

timolol; ophthalmic

117.0

323.0

1337

213

S01ED51

ATC

timolol, combinations; ophthalmic

403.7

323.0

2457

424

XCW99

NOMESCO Finland

Other investigative procedure of eye

7.9

323.0

944

1673

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

9992.3

323.0

755

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

9364.3

323.0

2574

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

5.6

323.0

2013

8552

S01EA02

ATC

dipivefrine; ophthalmic

883.9

323.0

384

S01EC04

ATC

brinzolamide; ophthalmic

277.7

323.0

1455

106

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

323.0

456

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

49.4

323.0

433

103

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

+∞

323.0

343

S01EC03

ATC

dorzolamide; ophthalmic

259.9

323.0

805

S01EC01

ATC

acetazolamide; systemic

138.0

323.0

1117

132

H40.0

ICD-10 Finland

Glaucoma suspect

239.6

323.0

834

Z96.1

ICD-10 Finland

Presence of intraocular lens

7.8

323.0

1338

2904

S01EE01

ATC

latanoprost; ophthalmic

175.6

323.0

1941

338

S01EE03

ATC

bimatoprost; ophthalmic

196.1

323.0

845

S01ED02

ATC

betaxolol; ophthalmic

130.3

323.0

460

S01EC54

ATC

brinzolamide, combinations; ophthalmic

409.9

323.0

474

CHD00

NOMESCO Finland

Laser trabeculoplasty

2272.1

323.0

530

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

+∞

323.0

502

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1078.0

323.0

1541

S01EB01

ATC

pilocarpine; ophthalmic

174.5

323.0

379

S01EX03

ATC

215.3

323.0

1127

S01EA03

ATC

apraclonidine; ophthalmic

65.2

323.0

433

H40.11

ICD-10 Finland

Low pressure glaucoma

482.5

323.0

380

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1517.6

323.0

995

S01EE04

ATC

travoprost; ophthalmic

106.9

323.0

704

H40.9

ICD-10 Finland

Glaucoma, unspecified

270.1

323.0

455

114

Kela drug reimbursment

Glaucoma

881.0

323.0

2695

510

S01EE05

ATC

tafluprost; ophthalmic

73.7

323.0

720

130

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

4.8

323.0

1973

9005

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

3549.3

323.0

327

XCK10

NOMESCO Finland

Photography of fundus of eye

7.7

323.0

884

1571

XCK00

NOMESCO Finland

Perimetry

40.2

323.0

1185

494

WX140

NOMESCO Finland

Parabulbar anesthesy

19.6

323.0

763

521

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

4.7

319.1

1983

9288

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

8.1

297.2

742

1179

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.7

273.4

938

2263

CHC05

NOMESCO Finland

Iridotomy

94.0

267.4

295

XCH00

NOMESCO Finland

Eye pressure measurement

14.7

265.7

467

375

XCH05

NOMESCO Finland

Eye pressure longterm registration

544.7

255.0

250

CHD35

NOMESCO Finland

Laser goniopuncture

2505.5

252.7

241

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

227.1

215

CHD99

NOMESCO Finland

Other filtering operation

+∞

220.7

209

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

12.8

214.0

399

358

H40

ICD-10 Finland

Glaucoma

76.1

209.8

238

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

161.7

200.5

210

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

196.1

186

H20.1

ICD-10 Finland

Chronic iridocyclitis

41.5

188.1

237

CS494

NOMESCO Finland

Other visual field testing

27.5

187.1

261

104

H25.1

ICD-10 Finland

Senile nuclear cataract

3.2

184.0

1542

7659

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

+∞

162.0

154

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

149.5

160.2

169

ZXC20

NOMESCO Finland

Use of chemical agents

11.5

146.9

286

274

WX100

NOMESCO Finland

Conjunctival surface anesthesia

3.8

146.6

744

2431

CFW99

NOMESCO Finland

Other operation on conjunctiva

1501.3

146.1

141

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

33.1

142.6

189

CJB10

NOMESCO Finland

Laser discission of secondary cataract

4.1

141.4

645

1912

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

5.7

127.4

395

775

H26.4

ICD-10 Finland

After-cataract

3.6

123.6

667

2251

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

22.7

123.0

181

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

14.4

115.1

200

148

S01BC03

ATC

diclofenac; ophthalmic

9.0

112.0

248

298

H40.8

ICD-10 Finland

Other glaucoma

553.3

108.5

107

ZXA05

NOMESCO Finland

Left side

2.6

108.4

1096

5533

H34.8

ICD-10 Finland

Other retinal vascular occlusions

9.0

103.8

230

276

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

103.8

ZXA00

NOMESCO Finland

Right side

2.5

103.6

1125

5869

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

8.9

102.6

228

275

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

991.5

98.7

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

97.4

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

4.5

92.2

356

875

ZXA10

NOMESCO Finland

Bilateral

2.6

90.4

808

3721

H26.2

ICD-10 Finland

Complicated cataract

16.5

88.6

145

CKC12

NOMESCO Finland

Photocoagulation of retina

6.1

85.4

245

429

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

6.0

82.7

241

430

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

+∞

82.7

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

+∞

81.6

WX002

NOMESCO Finland

Sedation and analgesia

2.5

80.2

772

3666

H33.0

ICD-10 Finland

Retinal detachment with retinal break

7.1

79.2

204

308

H43.1

ICD-10 Finland

Vitreous haemorrhage

8.0

79.0

186

245

CKD40

NOMESCO Finland

Endophotocoagulation of retina

13.3

78.8

141

111

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

25.0

78.2

111

H40.1

ICD-10 Finland

Primary open-angle glaucoma

166.6

77.5

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

6.8

76.3

201

313

H16.0

ICD-10 Finland

Corneal ulcer

5.7

71.0

217

409

F93

ICPC

Glaucoma

69.3

70.7

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

+∞

70.1

S01BC05

ATC

ketorolac; ophthalmic

3.9

69.1

309

861

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

9.7

68.6

144

156

3708

FHL

Trabeculectomy or equivalent

684.0

68.3

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

+∞

68.0

H3603, E103

ICD-10 Finland

22.8

65.2

CS2P4

NOMESCO Finland

Optic nerve head imaging

104.0

65.1

H40.12

ICD-10 Finland

Pigmentary glaucoma

+∞

64.8

CHD10

NOMESCO Finland

Trabeculectomy

+∞

64.8

CKD20

NOMESCO Finland

Removal of vitreous body substitute

21.6

63.4

H21.0

ICD-10 Finland

Hyphaema

40.6

62.9

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

22.1

61.2

WX142

NOMESCO Finland

Sub-tenon anesthesy

22.1

59.9

S01FA01

ATC

atropine; ophthalmic

24.4

58.2

H04.10

ICD-10 Finland

Dry eye syndrome

3.1

57.6

350

1231

CHC03

NOMESCO Finland

Laser iridoplasty

558.5

55.8

S01FA04

ATC

cyclopentolate; ophthalmic

11.2

55.4

107

37597

ICD-8 Finland

Glaucoma, Suspicio glaucomatis

+∞

54.3

TCG10

NOMESCO Finland

Removal of sutures from cornea

19.6

53.7

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

56.6

51.7

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

17.2

51.3

CFB00

NOMESCO Finland

Suture of conjunctiva

112.1

50.9

H3603, E113

ICD-10 Finland

11.5

49.6

H44.5

ICD-10 Finland

Degenerated conditions of globe

173.0

49.0

CKC15

NOMESCO Finland

Panretinal photocoagulation

11.0

49.0

CKD15

NOMESCO Finland

Injection of vitreous substitute

19.4

48.5

CKC20

NOMESCO Finland

Cryopexy of undetached retina

33.3

47.4

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

62.2

47.4

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

7.8

47.0

111

147

SPAT1009

SPAT

Measurement of intraocular pressure

8.8

46.7

102

119

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

9.6

46.1

103

S01EX

ATC

Other antiglaucoma preparations

+∞

44.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.5

44.9

121

194

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

+∞

42.8

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

42.8

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

6.9

41.3

106

159

H18.1

ICD-10 Finland

Bullous keratopathy

24.6

41.1

Z94.7

ICD-10 Finland

Corneal transplant status

19.2

40.6

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

16.0

40.5

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.8

39.9

177

485

S01GX01

ATC

cromoglicic acid; ophthalmic

2.1

39.0

477

2436

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.1

38.9

158

401

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

6.8

38.2

151

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

7.6

37.1

121

A10AA01

ATC

5.2

37.0

119

238

H25.0

ICD-10 Finland

Senile incipient cataract

2.7

36.8

272

1073

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

131.7

36.8

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.7

36.3

128

283

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

5.7

36.0

106

191

S01AX11

ATC

[U] ofloxacin; ophthalmic

3.2

34.2

194

644

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

16.5

34.2

H25.8

ICD-10 Finland

Other senile cataract

2.0

33.7

514

2858

A10AA02

ATC

3.4

33.3

169

517

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

23.9

33.1

CFD10

NOMESCO Finland

Repair of conjunctiva

55.0

32.3

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

14.6

31.5

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

5.2

31.2

195

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

42.7

30.9

H26.02

ICD-10 Finland

Presenil cataract

4.7

30.8

107

233

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.7

30.8

S01EX05

ATC

netarsudil; ophthalmic

+∞

30.3

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

12.9

29.3

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

29.0

131

365

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

6.6

28.5

114

T89

ICPC

Diabetes insulin dependent

4.0

28.1

117

304

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

10.8

28.0

H16.9

ICD-10 Finland

Keratitis, unspecified

6.3

27.9

121

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.8

27.6

142

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.8

27.4

121

331

H27.0

ICD-10 Finland

Aphakia

13.7

26.8

CG2T4

NOMESCO Finland

Topography assessment of cornea

9.8

26.2

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

26.1

H31.4

ICD-10 Finland

Choroidal detachment

94.3

25.7

S01AD03

ATC

aciclovir; ophthalmic

3.2

25.6

141

459

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

22.0

25.6

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

11.3

25.6

H27.1

ICD-10 Finland

Dislocation of lens

10.4

25.5

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.0

24.9

103

267

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

13.2

24.7

CWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in eye and adjacent structures

131.1

24.6

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

24.4

292

1461

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

5.0

24.4

165

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

11.1

23.8

A10AE04

ATC

insulin glargine; parenteral

2.0

23.7

308

1593

H04AA01

ATC

glucagon; nasal, parenteral

5.7

23.7

124

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

23.2

250

1195

E10

ICD-10 Finland

Type 1 diabetes mellitus

6.4

22.8

XCD20

NOMESCO Finland

Photoangiography of eye

3.8

22.7

269

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

121.0

22.6

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.0

22.5

131

444

CKD60

NOMESCO Finland

Anterior vitrectomy

5.5

21.7

121

H54.4

ICD-10 Finland

Blindness, monocular

18.5

21.7

H3601, E103

ICD-10 Finland

8.6

21.3

H57.1

ICD-10 Finland

Ocular pain

3.8

20.6

241

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.1

20.5

117

391

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

+∞

19.8

H36.01

ICD-10 Finland

Diabetic maculopathy

5.0

19.8

131

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

19.6

331

1882

F43

ICPC

Eye, Other diagnostic procedure

4.6

19.6

150

H54.1

ICD-10 Finland

Severe visual impairment, binocular

17.8

19.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

19.4

659

4592

H01.0

ICD-10 Finland

Blepharitis

2.6

19.1

141

554

XCW10

NOMESCO Finland

Assessment of vision

10.1

18.8

37512

ICD-8 Finland

Glaucoma, Chronicum capsulare

+∞

18.8

S01EB02

ATC

carbachol; ophthalmic

+∞

18.8

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

18.8

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

7.4

18.7

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

9.4

18.6

F99

ICPC

Eye/adnexa disease other

8.4

18.4

H33.4

ICD-10 Finland

Traction detachment of retina

13.6

18.2

H3600, E103

ICD-10 Finland

7.5

17.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

17.6

1203

9661

3711

FHL

Cyclodiateria or cryocoagulation

181.0

17.5

R3120

NOMESCO Finland

Training in mobility skills

31.6

17.0

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

10.8

16.9

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.4

16.9

143

607

H52.1

ICD-10 Finland

Myopia

4.2

16.9

155

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

+∞

16.7

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

16.7

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

35.2

16.7

CGG60

NOMESCO Finland

Reinforcement of sclera using graft

90.6

16.6

C08CA01

ATC

amlodipine; oral

1.4

16.1

1107

8856

J01DB01

ATC

cefalexin; oral

1.4

16.1

2028

18057

S01FA02

ATC

scopolamine; ophthalmic

5.5

16.0

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

21.1

16.0

WX110

NOMESCO Finland

Local anesthesy

1.4

16.0

1489

12564

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

15.9

808

6102

CWW99

NOMESCO Finland

Other reoperation on eye and adjacent structures

60.3

15.8

H20.8

ICD-10 Finland

Other iridocyclitis

15.7

H18.2

ICD-10 Finland

Other corneal oedema

15.7

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.0

15.6

H30.2

ICD-10 Finland

Posterior cyclitis

17.3

15.6

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

22.2

15.5

S01BA09

ATC

clobetasone; ophthalmic

38.3

15.4

H02.4

ICD-10 Finland

Ptosis of eyelid

2.8

15.3

354

H35.36

ICD-10 Finland

Macular cyst

6.1

15.3

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

2.9

15.2

334

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.7

15.2

104

394

CKD50

NOMESCO Finland

Endodiathermy of retina

20.1

15.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

14.9

521

3623

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

15.1

14.9

3663A

ICD-9 Finland

Cataract secondary to ocular disorders

12.5

14.8

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.3

14.8

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

14.8

300

1804

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

57.0

14.8

H3603, E109

ICD-10 Finland

57.0

14.8

A10AE05

ATC

insulin detemir; parenteral

2.1

14.8

161

774

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

14.7

223

1219

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

9.8

14.7

H26.3

ICD-10 Finland

Drug-induced cataract

7.5

14.7

3703

FHL

Laser operation on ventricular angle under general anesthesia

+∞

14.6

L04AB04

ATC

adalimumab; parenteral

4.9

14.5

Q15.0

ICD-10 Finland

Congenital glaucoma

150.7

14.5

3719

FHL

Other measure in this category

150.7

14.5

SPAT1262

SPAT

Handing over of treatment supplies

1.5

14.4

510

3557

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

14.3

1778

15596

CG2S4

NOMESCO Finland

Photography of cornea

9.1

14.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.3

14.1

119

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.3

14.0

F38

ICPC

Eye, Other laboratory test NEC

10.9

14.0

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

14.8

13.6

CKC60

NOMESCO Finland

Local buckling of sclera using implant

6.8

13.4

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.1

13.3

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.1

13.3

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

13.8

13.2

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.6

13.2

167

H3603, E107

ICD-10 Finland

40.2

13.1

J01CA04

ATC

amoxicillin; systemic

1.4

13.0

1908

17047

H54.0

ICD-10 Finland

Blindness, binocular

16.8

13.0

CDC00

NOMESCO Finland

Enucleation of eye

28.5

12.9

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.1

12.8

CKC70

NOMESCO Finland

Circular buckling of sclera

8.5

12.7

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

12.7

450

3135

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.9

12.6

179

956

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.9

12.5

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.6

12.5

352

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.9

12.5

CHC00

NOMESCO Finland

Iridotomy

130.5

12.4

A98

ICPC

Health maint/preventive medicine

1.4

12.4

2331

21600

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.2

12.3

199

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

14.4

12.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.0

12.1

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

46.8

11.9

H44.4

ICD-10 Finland

Hypotony of eye

46.8

11.9

S01KA02

ATC

hypromellose; ophthalmic

2.9

11.8

244

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

11.8

535

3917

A11CC03

ATC

alfacalcidol; systemic

2.7

11.6

295

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

5.0

11.5

H02AB06

ATC

prednisolone; systemic

1.3

11.5

1188

9986

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

8.6

11.5

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

10.1

11.5

3656F

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]

+∞

11.5

3661A

ICD-9 Finland

Cataract, Senile cataract

2.7

11.5

284

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

120.5

11.4

127

Kela drug reimbursment

Transplant complication

4.3

11.3

TK800

NOMESCO Finland

Hemodialysis

3.1

11.3

206

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

10.9

267

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

6.3

10.9

H54.5

ICD-10 Finland

Severe visual impairment, monocular

7.8

10.9

N02BE01

ATC

paracetamol; systemic, rectal

1.4

10.8

2258

20940

CHB15

NOMESCO Finland

Puncture of anterior chamber of eye with replacement of aqueous

21.5

10.7

H3601, E113

ICD-10 Finland

2.9

10.6

227

A02BC02

ATC

pantoprazole; systemic

1.3

10.6

1652

14646

J01AA02

ATC

doxycycline; systemic

1.3

10.5

1951

17712

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.2

10.5

106

495

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

7.3

10.4

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

7.3

10.4

H53.4

ICD-10 Finland

Visual field defects

2.8

10.4

241

N0830, E102

ICD-10 Finland

110.4

10.4

CHB30

NOMESCO Finland

Goniotomy

+∞

10.4

165

Kela drug reimbursment

Preservative-free combination of bimatoprost and timolol

+∞

10.4

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

32.6

10.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

10.3

982

8121

H18.8

ICD-10 Finland

Other specified disorders of cornea

5.3

10.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.1

10.3

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.6

10.2

123

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.7

10.2

215

1310

CJF20

NOMESCO Finland

Removal of artificial lens

14.6

10.0

L04AA17

ATC

[U] adalimumab; parenteral

14.6

10.0

H35.29

ICD-10 Finland

Other proliferative retinopathy

40.2

10.0

L04AA06

ATC

mycophenolic acid; systemic

3.6

9.9

121

J01FF01

ATC

clindamycin; systemic

1.4

9.8

597

4596

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.2

9.8

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

26.1

9.8

A10AE06

ATC

insulin degludec; parenteral

2.9

9.8

204

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

5.4

9.8

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

9.8

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

4.8

9.7

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

9.6

178

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

9.6

603

4661

F29

ICPC

Eye symptom/complaint other

1.7

9.6

181

1067

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

9.6

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

11.4

9.5

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

11.4

9.5

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.4

9.5

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

9.5

517

3901

CGG31

NOMESCO Finland

Posterior corneal lamellar transplantation

10.1

9.5

H221, M084

ICD-10 Finland

+∞

9.4

CHB50

NOMESCO Finland

Trabeculotomy

+∞

9.4

3659X

ICD-9 Finland

Glaucoma, Unspecified glaucoma

+∞

9.4

CHC10

NOMESCO Finland

Peripheral iridectomy

+∞

9.4

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.2

9.3

154

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

9.3

V03AE02

ATC

sevelamer; oral

6.9

9.3

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.2

9.2

150

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

9.2

179

1065

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

13.7

9.2

C10AA01

ATC

simvastatin; oral

1.3

9.1

1338

11668

H3600, E113

ICD-10 Finland

2.9

9.1

185

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.2

9.1

391

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

9.0

151

855

L04AA01

ATC

[U] ciclosporin; systemic

3.2

9.0

137

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

18.6

8.9

H18.4

ICD-10 Finland

Corneal degeneration

7.5

8.9

E0000UV

ATC

1.3

8.9

900

7471

H18.6

ICD-10 Finland

Keratoconus

6.8

8.8

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

3.1

8.8

150

CJF00

NOMESCO Finland

Secondary implantation of artificial lens in anterior chamber

10.7

8.8

R03AC02

ATC

salbutamol; inhalant

1.3

8.7

1159

9957

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

8.7

294

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.7

856

7071

S01FA06

ATC

tropicamide; ophthalmic

11.6

8.6

S05.6

ICD-10 Finland

Penetrating wound of eyeball without foreign body

11.6

8.6

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

4.2

8.6

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

9.0

8.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

8.5

681

5464

H34.1

ICD-10 Finland

Central retinal artery occlusion

4.1

8.4

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

5.6

8.4

3702

FHL

Trabeculotomy

+∞

8.3

3650B

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]

+∞

8.3

3651D

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA PIGMENTOSUM]

+∞

8.3

37511

ICD-8 Finland

Glaucoma, Chronicum irritativum sive congestivum

+∞

8.3

37598

ICD-8 Finland

Glaucoma, Aliud definitum

+∞

8.3

3652A

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[AKUUTTI AHDASKULMAGLAUKOOMA]

+∞

8.3

S01EXXX

ATC

+∞

8.3

WX144

NOMESCO Finland

Subconjunctival anesthesy

2.8

8.3

180

M45

ICD-10 Finland

Ankylosing spondylitis

3.0

8.2

153

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

4.5

8.2

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

8.0

186

1167

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

8.0

390

2880

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

7.9

152

905

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.6

7.9

222

A28

ICPC

Limited function/disability NOS

1.3

7.9

532

4153

H22.0*B02.3

ICD-10 Finland

Zoster iridocyclitis

10.8

7.8

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

10.8

7.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

7.8

H04.3

ICD-10 Finland

Acute and unspecified inflammation of lacrimal passages

4.8

7.7

H02AB04

ATC

methylprednisolone; systemic

1.4

7.7

343

2490

CDC40

NOMESCO Finland

Evisceration of eye with insertion of prosthesis

45.1

7.7

CHD60

NOMESCO Finland

Deep sclerectomy without implant

45.1

7.7

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

5.9

7.7

H46

ICD-10 Finland

Optic neuritis

7.4

7.7

4AA12

NOMESCO Finland

18.4

7.6

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

11.9

7.6

CJG15

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

25.1

7.6

AA1AD

NOMESCO Finland

CT of head and brain

1.3

7.5

665

5394

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

8.9

7.5

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.8

7.5

CBG00

NOMESCO Finland

Epilation of cilia by electrolysis

5.7

7.5

CD2S4

NOMESCO Finland

Photography of eye

5.7

7.5

A10AA03

ATC

3.1

7.5

128

T90

ICPC

Diabetes non-insulin dependent

1.3

7.4

571

4540

CDC10

NOMESCO Finland

Enucleation of eye with insertion of prosthesis

80.3

7.4

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.7

7.4

J05AB01

ATC

aciclovir; systemic

1.4

7.4

450

3455

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

7.3

179

1137

CHD20

NOMESCO Finland

Posterior sclerotomy

+∞

7.3

H3603, H405

ICD-10 Finland

+∞

7.3

S01EB03

ATC

ecothiopate; ophthalmic

+∞

7.3

CHD30

NOMESCO Finland

Laser trabeculectomy

+∞

7.3

H221, M083

ICD-10 Finland

+∞

7.3

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

7.3

110

606

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.8

7.3

130

755

H15.1

ICD-10 Finland

Episcleritis

4.0

7.3

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

20.1

7.1

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

7.9

7.1

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

7.1

342

2519

S01BC01

ATC

indometacin; ophthalmic

12.0

7.1

F27

ICPC

Fear of eye disease

3.8

7.0

H33.5

ICD-10 Finland

Other retinal detachments

4.3

7.0

L04AD01

ATC

ciclosporin; systemic

3.1

7.0

113

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

3.2

6.9

108

H05BX01

ATC

cinacalcet; oral

4.6

6.9

R53

ICD-10 Finland

Malaise and fatigue

1.3

6.9

560

4487

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

6.7

6.8

S01XA18

ATC

ciclosporin; ophthalmic

5.0

6.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.8

532

4242

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

40.1

6.8

3793C

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]

3.7

6.8

0147

NOMESCO Finland

16.7

6.7

WX720

NOMESCO Finland

Own respiration

2.0

6.7

398

B05DA

ATC

Isotonic solutions

4.7

6.7

C08CA13

ATC

lercanidipine; oral

1.4

6.7

370

2795

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.9

6.7

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

3.4

6.6

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

3.4

6.6

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.7

6.6

V03AE03

ATC

lanthanum carbonate; oral

6.8

6.5

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

2.8

6.5

135

H02AB07

ATC

prednisone; oral

1.4

6.5

354

2666

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

4.5

6.5

R01AD08

ATC

fluticasone; nasal

1.3

6.4

518

4137

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

6.4

741

6204

CWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures

70.0

6.4

S01XA02

ATC

retinol; ophthalmic

3.5

6.4

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.4

987

8550

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

6.4

423

H33.2

ICD-10 Finland

Serous retinal detachment

6.5

6.3

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.2

6.3

S01AA12

ATC

tobramycin; ophthalmic

5.2

6.3

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

6.3

123

736

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.3

996

8641

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

11.0

6.3

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

11.0

6.3

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

4.0

6.3

C03CA01

ATC

furosemide; systemic

1.2

6.3

1048

9149

S01FB01

ATC

phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)

18.0

6.3

ZZL00

NOMESCO Finland

Free graft of amniotic membrane

18.0

6.3

S01EA01

ATC

epinephrine; ophthalmic

+∞

6.2

3656C

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]

+∞

6.2

H40.2

ICD-10 Finland

Primary angle-closure glaucoma

+∞

6.2

3651C

ICD-9 Finland

Glaucoma, Open-angle glaucoma[MATALAPAINEGLAUKOOMA]

+∞

6.2

3651E

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA INFANTILE SEU JUVENILE]

+∞

6.2

CGG20

NOMESCO Finland

Epikeratofakia or keratofakia

+∞

6.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

6.2

107

618

H360, E113

ICD-10 Finland

26.7

6.2

H3603, E117

ICD-10 Finland

26.7

6.2

H18.3

ICD-10 Finland

Changes in corneal membranes

26.7

6.2

A02BC05

ATC

esomeprazole; systemic

1.2

6.2

917

7899

SPAT1325

SPAT

Vaccination

1.2

6.2

939

8109

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

6.2

120

719

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

6.1

184

S01GX08

ATC

ketotifen; ophthalmic

2.1

6.1

287

N18.0

ICD-10 Finland

End-stage renal disease

2.7

6.1

152

SPAT1014

SPAT

Treatment of eyes

2.2

6.1

266

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

3.2

6.1

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

4.0

6.1

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

12.5

6.1

3792A

ICD-9 Finland

Other disorders of eye, Disorders of vitreous body

12.5

6.1

H3602, E103

ICD-10 Finland

12.5

6.1

XQ800

NOMESCO Finland

Prick test

1.8

6.1

105

607

CGF10

NOMESCO Finland

Suture of laceration of cornea

8.6

6.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

6.0

388

3000

CJD20

NOMESCO Finland

Extracapsular cataract extraction with implantation of artificial lens in posterior chamber

6.7

6.0

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.7

6.0

N20.1

ICD-10 Finland

Calculus of ureter

1.9

6.0

437

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

6.0

266

1928

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte distribution width [Ratio]

2178

18361

1.58

30.63

25.6

21.6

14.0

0.45

2128

17881

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

15.44

26.24

7.9

7.2

—

(42870588) Differential panel, method unspecified - Blood

1121

8393

1.52

25.83

6.7

5.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

489

3004

1.74

25.53

2.2

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2713

24611

1.66

23.33

25.0

21.1

mmol/l

139.3

139.5

2.94

2633

23864

(3023103) Potassium [Moles/volume] in Serum or Plasma

2716

24655

1.66

23.17

25.4

21.3

mmol/l

4.0

0.02

2632

23862

(3042733) HLA Ab [Presence] in Serum

8.78

21.54

5.7

4.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2608

23554

1.57

21.46

21.3

17.7

mg/l

25.8

26.9

0.90

2191

19373

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2212

19353

1.46

20.82

8.0

7.4

u/l

81.3

81.7

0.11

2071

17967

(3022096) Basophils/100 leukocytes in Blood

1363

10930

1.43

20.76

7.2

5.6

0.6

0.18

1261

10038

(3037467) Urinalysis macro (dipstick) panel - Urine

2027

17499

1.43

20.11

5.5

4.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1396

11301

1.42

19.88

7.2

5.6

59.7

58.8

2.01

1289

10399

(3019198) Lymphocytes [#/volume] in Blood

1483

12136

1.41

19.84

7.2

5.5

e9/l

1.9

0.02

1294

10425

(3002030) Lymphocytes/100 leukocytes in Blood

1416

11498

1.41

19.78

7.5

5.8

25.3

26.0

1.31

1305

10524

(3006504) Eosinophils/100 leukocytes in Blood

1388

11232

1.42

19.77

7.2

5.7

2.9

2.8

1.37

1285

10310

(3026250) Tacrolimus [Mass/volume] in Blood

6.28

19.73

44.3

27.8

ug/l

7.5

6.6

1.28

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1458

11908

1.41

19.66

2.2

2.1

pmol/l

95.1

93.4

0.58

683

6030

(3019069) Monocytes/100 leukocytes in Blood

1391

11282

1.41

19.45

7.5

6.0

9.0

8.9

0.39

1290

10379

(3018418) pH of Serum or Plasma

1068

8282

1.43

19.15

5.5

3.8

7.4

2.95

222

1489

(3006315) Basophils [#/volume] in Blood

1453

11898

1.40

19.11

6.9

5.4

e9/l

0.0

1.12

1252

10050

(3007461) Platelets [#/volume] in Blood

2751

25326

1.60

19.00

30.8

25.9

e9/l

245.4

242.9

1.09

2652

24462

(3024731) MCV [Entitic volume]

2751

25331

1.60

18.93

30.7

25.8

92.1

91.6

5.23

2690

24744

(3035941) MCH [Entitic mass]

2751

25332

1.60

18.91

30.6

25.8

30.4

30.3

1.28

2691

24744

(3026361) Erythrocytes [#/volume] in Blood

2751

25333

1.60

18.90

30.8

25.9

e12/l

4.3

4.4

7.14

2630

24367

(3000963) Hemoglobin [Mass/volume] in Blood

2751

25339

1.60

18.81

31.1

26.1

g/l

129.7

131.2

6.06

2694

24760

(3010813) Leukocytes [#/volume] in Blood

2751

25340

1.60

18.80

30.8

25.9

e9/l

7.1

6.9

0.99

2635

24369

(3001604) Monocytes [#/volume] in Blood

1444

11841

1.40

18.69

7.0

5.4

e9/l

0.6

2.17

1245

9977

(3021589) Normoblasts [#/volume] in Blood

1279

10283

1.41

18.53

13.1

10.2

e9/l

0.0

0.91

1081

8245

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2671

24457

1.55

18.52

12.6

11.0

u/l

23.5

24.0

0.59

2554

23253

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1522

12649

1.39

17.90

7.4

5.7

mmol/l

1.2

1.76

1365

11268

(3013115) Eosinophils [#/volume] in Blood

1484

12283

1.39

17.88

7.1

5.6

e9/l

0.2

1.50

1293

10523

(3031040) Bacteria [#/volume] in Urine by Automated count

2003

17423

1.40

17.87

6.0

5.5

e6/l

136.7

3448.0

6.33

313

(40761511) CBC panel - Blood by Automated count

2606

23783

1.51

17.87

20.2

17.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2407

21652

1.45

17.54

20.1

16.8

ml/min/173m2

70.5

71.7

1.64

1982

17899

(3030467) Casts [#/volume] in Urine by Automated count

986

7638

1.42

17.41

3.9

3.4

e6/l

0.4

0.5

1.97

767

5867

(3026782) Osmolality of Urine

765

5669

1.46

17.15

3.2

2.9

mosm/kgh2o

510.9

539.9

3.69

661

4809

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1657

14025

1.38

17.11

8.2

6.5

mmol/l

1.2

0.10

1366

11731

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1293

10522

1.38

16.98

2.5

2.2

nmol/l

78.3

80.1

1.39

1119

9085

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

966

7496

1.41

16.76

2.4

2.3

mg/l

3.1

3.2

0.15

815

6307

(3014148) Varicella zoster virus Ab [Titer] in Serum

137

3.77

16.72

1.1

—

(36304419) Bacteria [Presence] in Urine

947

7329

1.41

16.66

4.0

3.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

152

3.60

16.54

1.2

1.3

—

(3018095) Leukocytes [#/volume] in Urine

1179

9519

1.38

15.97

4.9

3.9

e6/l

133.6

141.5

0.09

871

6916

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1225

9993

1.37

15.40

3.3

2.9

ug/l

147.5

146.0

0.07

1084

8969

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

426

2857

1.57

15.26

3.8

3.9

—

(3002582) Erythrocytes [#/volume] in Urine

1050

8373

1.38

15.16

4.1

3.5

e6/l

157.8

76.2

0.65

823

6505

(3023368) Bacteria identified in Blood by Culture

1047

8346

1.38

15.15

4.9

4.2

—

(3044889) 12 lead EKG panel

1929

16894

1.36

15.13

4.6

4.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1441

12089

1.35

14.96

4.6

4.3

estimate

0.0

0.00

331

2186

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2390

21706

1.40

14.60

7.6

6.5

mmol/mol

42.7

41.0

11.78

2126

19546

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2360

21398

1.39

14.49

5.1

5.0

mu/l

2.1

0.22

2090

19029

(3009542) Hematocrit [Volume Fraction] of Blood

2243

20188

1.37

14.28

23.7

19.3

37.1

38.0

2.82

1380

12327

(3032080) INR in Blood by Coagulation assay

1391

11673

1.34

14.14

11.8

11.1

inr

1.3

1.4

0.09

415

3053

(3013707) Erythrocyte sedimentation rate by Westergren method

2027

17987

1.34

13.99

4.6

4.2

mm/h

15.9

15.0

1.36

1846

16317

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

166

3.23

13.81

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

332

2172

1.59

13.16

1.7

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1415

11994

1.32

13.05

5.2

4.5

g/l

34.0

34.5

2.57

1298

10969

(3003458) Phosphate [Moles/volume] in Serum or Plasma

506

3630

1.47

13.05

8.6

5.0

mmol/l

1.1

1.0

2.51

465

3287

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.10

13.01

1.1

1.2

—

(3026008) Bacteria identified in Urine by Culture

1167

9634

1.33

12.92

4.0

3.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1442

12277

1.32

12.80

4.8

4.4

estimate

0.0

0.44

313

2151

(3013650) Neutrophils [#/volume] in Blood by Automated count

1615

13994

1.31

12.50

9.2

8.4

e9/l

4.4

4.3

0.55

1403

12044

(3012516) Albumin [Mass/volume] in Urine

967

7798

1.34

12.45

3.8

3.1

mg/l

366.9

323.8

0.11

632

4910

(3021960) Folate [Moles/volume] in Serum or Plasma

888

7070

1.35

12.44

1.6

nmol/l

20.6

20.4

0.12

758

5910

(3021601) Nitrite [Presence] in Urine by Test strip

1421

12110

1.31

12.38

6.3

5.8

estimate

0.0

0.50

327

2163

(3020682) Albumin/Creatinine [Ratio] in Urine

1016

8265

1.34

12.30

4.8

3.9

mg/mmol

17.8

9.0

2.84

665

5161

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

595

4447

1.41

12.23

3.4

3.1

e6/l

1.9

2.7

2.70

342

2487

(40768446) Kidney Pathology biopsy report

4.62

12.11

1.9

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

344

2322

1.54

11.86

4.9

3.4

ng/l

107.4

94.9

1.30

291

1921

(3013826) Glucose [Moles/volume] in Serum or Plasma

1754

15443

1.30

11.73

6.3

4.6

mmol/l

7.1

6.9

4.02

1648

14519

(3009508) Creatinine [Moles/volume] in Urine

979

7968

1.33

11.68

3.7

3.1

mmol/l

6.5

6.8

1.84

797

6520

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

349

2.36

11.56

1.7

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2462

22742

1.35

11.51

5.5

5.2

mmol/l

2.5

2.6

5.47

2178

20299

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

350

2.35

11.49

1.7

1.2

—

18.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1176

9847

1.31

11.37

4.2

3.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1557

13540

1.29

11.25

5.5

5.9

umol/l

11.9

12.2

0.26

1459

12762

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

116

594

1.99

10.74

3.8

2.6

mg/l

1.8

1.7

0.34

106

521

(3022948) Iron [Moles/volume] in Serum or Plasma

591

4506

1.38

10.67

3.4

2.5

umol/l

11.2

11.9

1.63

540

4102

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

526

3935

1.40

10.63

3.6

2.5

20.8

21.2

0.35

438

3304

(3025159) Blasts/100 leukocytes in Blood

272

1788

1.57

10.54

3.9

4.1

0.1

0.3

0.51

478

(3024471) HLA-A [Type]

5.43

10.39

1.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

551

4181

1.38

10.21

3.5

2.5

g/l

2.2

2.3

4.05

500

3817

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

389

2.19

10.16

8.5

4.6

iu/ml

467.3

831.3

0.41

(3015736) pH of Urine

1136

9586

1.29

10.02

4.2

4.0

—

6.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

613

4745

1.36

10.01

3.3

2.9

e6/l

1.2

1.3

0.55

356

2766

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

877

7154

1.31

10.00

3.1

3.0

u/l

29.2

36.0

4.07

826

6727

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

303

2.34

9.94

1.9

1.3

u/ml

113.1

116.6

0.15

(3024932) HLA-DR beta [Type]

5.45

9.92

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2435

22608

1.32

9.92

5.2

5.0

mmol/l

6.3

6.1

8.62

2117

19930

(3000850) Epithelial cells [#/volume] in Urine

744

5946

1.33

9.79

3.2

2.7

e6/l

5.6

5.4

0.23

657

5219

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1958

17703

1.27

9.64

4.1

4.0

pmol/l

15.1

0.07

1718

15649

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

154

902

1.74

9.38

1.7

u/l

39.0

38.7

0.06

137

767

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1271

10939

1.27

9.38

4.6

4.3

ng/l

45.1

117.8

1.10

980

8442

(3012095) Magnesium [Moles/volume] in Serum or Plasma

559

4307

1.36

9.35

3.0

2.8

mmol/l

0.8

0.64

505

3923

(40767503) Oxygen content in Capillary blood by calculation

112

598

1.90

9.23

2.5

15.9

15.6

0.23

312

(40761536) Microorganisms panel - Urine sediment

294

2028

1.50

9.12

5.3

4.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

796

6477

1.30

9.11

1.9

1.8

nmol/l

1141.9

1161.9

0.24

586

4744

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2370

22033

1.29

8.85

4.9

4.6

mmol/l

4.4

4.5

4.08

2104

19732

(3042936) Bacteria identified in Isolate by Culture

490

3744

1.36

8.60

2.6

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2344

21793

1.28

8.55

4.8

4.6

mmol/l

1.4

1.5

1.18

2062

19383

(3041096) Erythrocytes [Presence] in Urine by Automated

761

6203

1.30

8.51

4.3

4.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

720

5827

1.30

8.50

1.8

1.6

mmol/l

1.3

0.03

587

4829

(3021440) Promyelocytes/100 leukocytes in Blood

279

1935

1.48

8.43

3.9

4.0

0.1

0.31

579

(3010421) pH of Blood

127

730

1.77

8.30

5.6

4.4

7.4

2.82

107

605

(3002179) Metamyelocytes/100 leukocytes in Blood

266

1834

1.49

8.28

3.8

0.5

0.6

0.15

432

(3036481) Cortisol [Moles/volume] in Serum or Plasma

299

2110

1.46

8.27

2.0

nmol/l

382.8

378.6

0.14

266

1886

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

145

2.78

8.22

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.76

8.11

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

152

2.72

8.08

2.3

2.4

—

(3017181) Myelocytes/100 leukocytes in Blood

290

2044

1.46

8.08

3.9

4.0

0.8

0.9

0.56

627

(3033658) Prothrombin time (PT) actual/Normal

783

6461

1.28

7.88

4.6

3.8

85.5

84.3

0.63

764

6292

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1107

9526

1.25

7.78

3.2

ng/l

2124.4

1970.2

0.42

948

8262

(3027945) Reticulocytes/100 erythrocytes in Blood

472

3642

1.35

7.73

2.4

2.3

1.8

0.09

404

3153

(3012501) Base excess in Blood by calculation

110

620

1.80

7.70

5.4

4.7

mmol/l

2.6

2.8

0.49

437

(3000494) Fungus identified in Specimen by Culture

362

2682

1.39

7.65

1.5

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

796

6605

1.27

7.62

5.2

4.7

estimate

0.0

1.08

305

2075

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

322

2347

1.41

7.48

3.3

2.3

u/l

36.8

56.3

0.45

271

1975

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

318

2313

1.42

7.47

5.8

3.6

mmol/l

1.2

0.52

278

1974

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

460

1.92

7.45

5.5

2.7

—

(3008898) HLA-B27 [Presence]

472

1.89

7.23

1.1

—

(40758558) Short blood count panel - Blood

745

6173

1.27

7.16

7.0

6.5

—

(1616796) Gas panel - Central venous blood

107

616

1.76

7.01

3.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.59

6.93

1.1

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

623

5079

1.28

6.79

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1090

9474

1.23

6.75

3.4

3.3

mmol/l

2.3

2.4

0.97

914

7989

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

451

1.86

6.58

4.3

3.4

56.8

59.3

0.72

451

(3037522) Nuclear Ab [Titer] in Serum

351

2651

1.36

6.58

1.3

titre

492.6

550.0

0.29

607

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.73

6.58

1.7

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1060

9207

1.23

6.57

5.1

4.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

173

1150

1.53

6.45

1.5

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1268

11244

1.21

6.32

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

633

5218

1.27

6.26

1.6

1.7

mg/l

1.6

1.5

0.22

494

4057

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

739

6204

1.25

6.24

1.8

1.7

pmol/l

27226482.2

14040841.1

0.29

584

4950

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2248

21069

1.22

6.23

4.3

4.1

mmol/l

1.3

0.12

1956

18538

(40768804) Tissue Pathology biopsy report

1085

9487

1.22

6.22

2.2

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

449

3556

1.31

6.08

1.9

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

932

8040

1.22

6.08

3.5

2.5

u/l

63.2

58.1

0.47

844

7316

(3018677) aPTT in Platelet poor plasma by Coagulation assay

529

4295

1.28

5.91

2.0

30.4

30.1

0.45

508

4137

(3020779) Urea [Moles/volume] in Serum or Plasma

331

2522

1.35

5.87

11.8

6.2

mmol/l

12.7

11.4

2.02

313

2355

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

211

1491

1.44

5.84

7.8

8.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.16

5.74

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

119

749

1.61

5.66

1.4

ug/g

264.5

276.6

0.30

444

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

443

3543

1.29

5.56

1.9

1.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.50

5.51

10.8

15.9

mmol/l

4.2

5.4

1.19

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

291

1.98

5.50

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

193

1360

1.45

5.44

7.9

3.3

mmol/l

23.6

24.2

1.64

174

1210

(3020630) Protein [Mass/volume] in Serum or Plasma

329

2545

1.33

5.27

2.4

2.5

g/l

66.5

66.0

0.65

281

2233

(3017143) Hepatitis C virus Ab [Presence] in Serum

246

1824

1.38

5.20

2.2

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

586

1.66

5.18

1.5

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.09

5.06

23.6

26.0

ug/l

102.5

114.4

0.43

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

665

5650

1.22

4.90

4.4

4.3

ng/l

459.5

485.0

0.04

583

4898

(3011397) Hemoglobin [Presence] in Urine by Test strip

702

6005

1.22

4.83

4.7

4.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

101

2.59

4.80

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

955

8415

1.19

4.78

2.1

u/l

160.8

218.3

2.70

879

7807

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

328

1.85

4.77

1.4

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.75

4.77

2.7

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

267

2037

1.34

4.72

2.2

1.5

—

(3003396) Base excess in Arterial blood by calculation

416

3369

1.27

4.71

6.1

5.9

mmol/l

0.8

1.3

1.34

308

2593

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

680

1.58

4.71

2.0

2.2

g/l

123.8

125.6

0.28

490

(3027801) Oxygen [Partial pressure] in Arterial blood

416

3375

1.27

4.65

6.1

5.9

kpa

11.9

11.8

0.07

389

3184

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

416

3376

1.27

4.63

6.1

5.9

kpa

5.0

5.1

0.32

388

3185

(3052851) Hemolysis interference index of Serum or Plasma

133

901

1.50

4.63

4.1

3.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

1142

1.44

4.61

2.2

2.4

g/l

11.2

10.4

1.26

124

938

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

205

1508

1.38

4.58

7.3

mmol/l

23.8

24.5

1.62

189

1378

(3016502) Oxygen saturation in Arterial blood

373

2992

1.28

4.57

6.3

6.1

95.4

95.2

0.20

353

2866

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

305

1.85

4.52

1.4

1.1

u/ml

338.8

289.0

0.60

171

(3025941) Bacteria identified in Stool by Culture

171

1222

1.42

4.52

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

549

4614

1.23

4.47

5.2

4.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

1.73

4.47

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

224

1.98

4.35

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

130

889

1.48

4.34

2.4

2.5

g/l

0.1

0.0

0.11

109

794

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

137

951

1.46

4.25

2.3

2.4

g/l

36.1

37.0

1.02

108

781

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

523

4396

1.23

4.25

3.5

3.3

ug/l

0.8

0.81

384

3116

(3023520) Reticulocytes [#/volume] in Blood

341

2731

1.28

4.24

2.6

2.4

e9/l

70.9

68.6

0.59

253

2076

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

474

1.64

4.10

1.7

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

141

992

1.44

4.09

3.0

3.1

ratio

2.0

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

1122

1.41

4.01

2.2

2.5

g/l

3.1

3.2

0.28

116

860

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

1.77

4.01

1.3

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

750

6558

1.19

4.00

2.8

umol/l

9426.1

7531.2

0.37

608

5473

(46235355) HIV 1 and 2 tests - Meaningful Use set

293

2320

1.29

3.99

2.1

1.6

—

(3013512) EKG study

907

8061

1.17

3.98

4.6

4.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1476

13627

1.15

3.90

3.1

u/l

49.2

54.4

1.57

1336

12282

(3002173) Hemoglobin [Mass/volume] in Arterial blood

336

2715

1.27

3.89

6.9

6.5

g/l

118.2

118.9

0.26

320

2613

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

879

7805

1.17

3.89

5.6

5.4

ug/l

4.0

4.6

0.25

765

6857

(3048929) Epstein Barr virus Ab [Presence] in Serum

435

1.65

3.87

1.4

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

292

1.79

3.86

1.2

miu/ml

244.1

238.8

—

106

(3036489) Thrombin time

117

804

1.47

3.85

1.8

1.9

21.7

21.6

0.02

104

736

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1209

1.38

3.82

2.2

2.4

g/l

4.2

3.8

1.25

113

840

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1211

1.38

3.79

2.2

2.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

142

1016

1.42

3.78

3.0

3.1

mg/l

32.9

68.9

1.86

115

842

(3009343) pH of Capillary blood

237

1839

1.31

3.77

3.6

7.4

0.56

227

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1213

1.38

3.75

2.2

2.4

g/l

7.8

7.5

0.97

115

873

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

349

2847

1.25

3.73

2.7

2.4

umol/l

10.8

9.6

0.25

290

2439

(3034860) Kappa light chains.free [Mass/volume] in Serum

142

1019

1.41

3.72

3.1

mg/l

51.0

117.4

0.64

115

842

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

230

1781

1.31

3.72

3.6

3.5

mmol/l

1.7

2.0

0.49

154

1307

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

143

1028

1.41

3.71

2.4

2.6

g/l

1.4

1.2

0.22

111

854

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

592

1.54

3.66

1.9

2.1

91.6

88.4

0.74

565

(3002032) Base excess in Venous blood by calculation

349

2856

1.25

3.64

6.0

3.3

mmol/l

1.3

2.1

3.17

275

2290

(3021447) Carbon dioxide [Partial pressure] in Venous blood

350

2869

1.25

3.59

5.7

3.3

kpa

5.9

5.8

0.20

332

2782

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

595

1.53

3.59

1.6

iu/ml

0.6

1.2

0.23

147

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

767

1.46

3.58

1.9

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

238

1862

1.30

3.58

3.7

3.6

kpa

5.2

0.16

214

1683

(3014111) Lactate [Moles/volume] in Serum or Plasma

312

2526

1.26

3.57

7.1

5.4

mmol/l

1.4

0.07

302

2421

(3028433) Virus identified in Specimen by Culture

2.51

3.54

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

144

2.09

3.53

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

145

2.08

3.47

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

511

4370

1.20

3.47

1.3

1.2

u/ml

1.2

1.6

0.44

130

1060

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

117

823

1.44

3.45

2.4

2.5

g/l

0.0

0.00

744

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

644

5629

1.18

3.41

3.1

3.0

mmol/l

2.5

0.00

537

4873

(3024980) IgG subclass 4 [Mass/volume] in Serum

282

1.75

3.39

1.4

1.5

g/l

0.5

0.9

2.46

212

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

228

1788

1.30

3.38

1.5

—

(3000991) Gas panel - Venous blood

294

2381

1.26

3.37

10.1

6.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

118

836

1.43

3.35

2.4

2.5

g/l

0.0

0.00

745

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

306

1.71

3.34

1.3

1.4

u/l

783.1

292.3

0.49

291

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1.96

3.28

1.3

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

109

765

1.44

3.27

2.5

3.1

mmol/l

24.7

25.2

0.46

102

663

(3045424) Erythrocytes [Presence] in Urine

393

1.62

3.25

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

268

2158

1.26

3.23

2.5

2.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

588

1.49

3.17

1.4

1.5

g/l

0.2

0.52

554

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

616

1.47

3.09

2.1

2.2

g/l

3.7

3.6

0.22

583

(3048689) Calprotectin [Mass/mass] in Stool

279

2272

1.25

3.06

2.0

1.9

ug/g

108.3

159.0

2.77

213

1731

(3003181) Sodium [Moles/volume] in Urine

577

1.49

3.04

1.3

mmol/l

59.6

61.2

0.16

454

(3027135) IgG subclass 1 [Mass/volume] in Serum

167

1.93

3.04

1.3

g/l

6.5

7.1

0.43

118

(3024139) IgG subclass 3 [Mass/volume] in Serum

167

1.93

3.04

1.4

1.3

g/l

0.3

0.4

1.28

118

(3028192) IgG subclass 2 [Mass/volume] in Serum

167

1.93

3.04

1.3

g/l

3.0

2.8

0.15

119

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

586

1.48

3.03

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

300

1.68

3.02

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

196

1.85

3.02

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

106

755

1.42

2.97

1.5

1.6

—

(3000492) Spirometry study

223

1779

1.27

2.93

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

243

1.74

2.90

1.2

u/ml

5.3

4.6

0.08

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

244

1971

1.26

2.89

1.8

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

148

1119

1.34

2.89

2.7

u/ml

0.3

0.4

1.06

671

(3036525) Urea [Moles/time] in 24 hour Urine

5.39

2.87

3.3

4.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

394

3351

1.20

2.85

3.3

3.8

u/l

243.0

248.7

0.41

360

3115

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

137

1028

1.35

2.82

1.4

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

604

1.45

2.81

1.4

1.5

g/l

1.2

0.53

569

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

276

1.68

2.80

1.4

1.3

pmol/l

270.6

260.4

0.07

201

(3052592) Norovirus Ag [Presence] in Stool

2.47

2.78

1.1

1.4

—

(3045414) Leukocytes [Presence] in Urine

146

1109

1.33

2.77

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.17

2.76

1.5

1.1

—

(3000012) Reticulocyte production index

152

1.92

2.75

1.7

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

616

1.44

2.73

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

452

1.52

2.73

1.5

1.6

—

(3025315) Body weight

5.01

2.72

5.7

4.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

365

1.57

2.70

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

289

2399

1.22

2.69

4.8

2.8

kpa

4.7

4.4

1.24

272

2317

(40760888) Immunoglobulin light chains.free panel - Serum

106

771

1.39

2.66

3.0

3.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

545

1.46

2.65

2.2

2.4

209.5

204.5

0.21

521

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

621

1.43

2.63

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.43

2.54

1.8

1.2

—

(3004775) Volume in Urine collected for unspecified duration

208

1.74

2.53

2.6

2.2

588.7

635.1

0.35

122

(3019060) Gas panel - Arterial blood

243

1995

1.24

2.52

3.9

4.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

157

1.85

2.52

1.2

—

(4062490)

172

1.81

2.50

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

129

979

1.33

2.50

2.4

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

444

3862

1.17

2.49

1.7

1.5

g/l

2.4

2.7

1.48

250

2165

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

695

6252

1.14

2.47

4.6

4.7

22.9

22.1

0.67

344

3299

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.83

2.47

1.1

1.2

—

(3036603) Volume of Urine

144

1.88

2.46

2.0

1.5

1701.8

1768.3

—

(3011985) Renin [Units/volume] in Plasma

295

1.60

2.45

1.5

1.3

mu/l

49.8

59.4

0.23

253

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.24

2.44

1.0

1.1

ratio

1.1

—

(3008295) Osmolality of Serum or Plasma

272

1.63

2.43

1.5

1.3

mosm/kgh2o

272.1

275.2

0.47

190

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

489

1.46

2.43

1.7

iu/l

2.8

4.5

2.31

155

(3017732) Neutrophils [#/volume] in Blood

193

1554

1.26

2.39

3.3

3.2

e9/l

4.5

4.1

1.08

139

1107

(3020876) Protein [Mass/time] in 24 hour Urine

212

1.71

2.39

1.9

—

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

467

1.47

2.37

1.5

1.6

g/l

29.1

30.5

0.33

419

(40768797) Stomach Pathology biopsy report

377

3249

1.18

2.37

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.64

2.36

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

169

1343

1.27

2.34

2.5

au/ml

27.8

25.1

—

(3004451) EKG impression Narrative

147

1.84

2.32

1.4

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

268

1.61

2.32

1.3

nmol/l

—

(3022145) Colonoscopy Study observation

295

2494

1.20

2.31

1.3

—

(3037756) Immunofixation for Serum or Plasma

689

1.38

2.30

1.6

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

141

1.85

2.27

2.6

2.2

ug/min

45.1

78.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

262

1.61

2.26

1.2

1.4

—

(3016750) Collection duration of Urine

142

1.84

2.23

2.6

2.0

min

487.5

497.7

0.20

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

5.8

5.3

—

(3002256) Pathology report gross observation

366

3167

1.18

2.20

1.4

—

(3018572) Chloride [Moles/volume] in Blood

635

1.38

2.20

5.5

6.2

mmol/l

105.0

104.9

0.06

569

(3039000) Anion gap in Blood

635

1.38

2.20

5.5

6.2

mmol/l

11.6

11.0

0.92

569

(3005322) IgE [Units/volume] in Serum or Plasma

135

1053

1.29

2.19

1.2

u/ml

237.4

200.1

0.13

122

954

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1241

11635

1.11

2.15

4.4

4.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

362

1.50

2.15

1.2

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

157

1252

1.27

2.14

4.5

4.6

0.9

1.03

143

1181

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

733

1.35

2.13

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

733

1.35

2.13

1.3

—

(4034850)

800

0.68

2.13

19.7

12.2

—

(3003338) MCHC [Mass/volume]

1935

18562

1.11

2.12

28.5

23.5

g/l

329.8

330.6

3.74

1907

18316

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.05

2.11

2.2

1.3

ug/l

15.5

9.6

0.29

(3026480) Teichoate Ab [Titer] in Serum

3.21

2.09

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

206

1.66

2.07

1.7

2.0

u/l

399.1

2215.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.91

2.07

1.8

1.5

umol/l

55.9

43.4

—

(3051611) Lipemic interference index of Serum or Plasma

341

1.50

2.06

3.8

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

703

1.35

2.06

2.6

3.0

kpa

8.1

7.9

0.54

646

(21494815) CD4 cells/100 lymphocytes in Specimen

146

1.79

2.06

1.9

39.9

40.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

440

1.44

2.06

8.7

1.4

nmol/l

0.8

0.03

353

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.51

2.05

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

161

0.37

2.01

1.3

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.34

1.96

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.34

1.96

1.0

1.1

90.3

98.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.98

1.95

3.6

2.9

—

(3047181) Lactate [Moles/volume] in Blood

114

885

1.30

1.95

5.1

5.6

mmol/l

1.2

1.3

0.64

783

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.75

1.93

1.0

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

902

8357

1.11

1.93

2.6

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

113

1.86

1.91

1.1

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

323

1.49

1.91

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

219

1.60

1.90

2.6

3.1

mg/l

66.2

22.3

0.46

168

(3014576) Chloride [Moles/volume] in Serum or Plasma

410

3626

1.15

1.88

7.3

5.7

mmol/l

104.6

104.1

1.06

401

3525

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.09

1.86

1.1

1.5

13.2

22.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

106

821

1.30

1.85

1.1

—

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.98

1.84

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.21

1.84

2.7

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

4.17

1.82

3.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

214

1.60

1.82

1.1

107.0

114.0

0.68

192

(3021387) Prolactin [Units/volume] in Serum or Plasma

335

1.47

1.82

2.0

1.6

mu/l

375.7

284.5

0.74

304

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

129

1028

1.27

1.81

2.2

2.1

ug/l

660.9

594.6

0.07

120

964

(40768806) Pleura Pathology biopsy report

360

1.45

1.81

1.5

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

254

1.54

1.81

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

156

1272

1.24

1.80

1.7

1.8

ug/l

2.9

2.3

0.23

127

1081

(3051101) Glucose [Moles/volume] in Cord blood

2.17

1.77

6.3

5.7

—

(3021901) Oxygen saturation in Capillary blood

574

1.35

1.77

2.5

2.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

281

1.50

1.74

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

155

1269

1.23

1.73

4.4

4.6

1.6

0.02

142

1198

(4306422)

217

1.57

1.73

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

241

1.54

1.73

1.3

1.2

u/ml

1.9

5.1

—

116

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

218

1.57

1.70

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

108

853

1.28

1.66

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

427

1.39

1.64

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

151

1242

1.23

1.63

3.2

3.1

pmol/l

4.4

0.04

130

1061

(3047189) Immunofixation for 24 hour Urine

128

1.72

1.60

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

370

1.41

1.60

6.5

6.2

mg/l

11.6

12.6

0.90

337

(3010503) CD19 cells [#/volume] in Blood

121

1.74

1.58

2.6

2.0

e9/l

0.1

0.91

114

(3016330) Potassium [Moles/time] in 24 hour Urine

3.00

1.58

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

656

1.30

1.57

2.9

2.3

ug/min

92.2

77.5

0.17

377

(3011412) CD3 cells [#/volume] in Blood

183

1.59

1.57

2.7

2.0

e9/l

0.8

1.0

0.60

108

(3011648) Oxygen content in Venous blood

183

1.59

1.57

3.2

1.5

10.6

0.01

183

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

129

1.71

1.56

2.6

1.9

e6/l

450.2

645.5

1.30

(3022493) Free Hemoglobin [Mass/volume] in Plasma

107

1.78

1.54

1.4

4.9

mg/l

45.2

65.4

1.45

(3024928) Oxygen saturation in Venous blood

571

1.32

1.53

5.2

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

157

1307

1.21

1.53

2.2

1.8

g/l

1.5

1.4

0.05

139

1157

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

340

1.42

1.52

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

192

1631

1.19

1.51

3.0

2.7

g/l

10.3

10.7

0.67

174

1466

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

279

2443

1.16

1.51

1.3

1.4

—

(4027681)

1.86

1.50

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

308

1.43

1.49

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

151

1256

1.21

1.49

2.2

2.1

nmol/l

10.3

11.6

1.11

134

1071

(1761868) Lipid panel - Serum or Plasma

658

6078

1.10

1.48

3.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

217

1867

1.17

1.47

4.9

3.0

g/l

122.4

126.7

2.03

206

1824

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

211

1.52

1.45

1.2

1.5

—

1466.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

181

1536

1.19

1.45

1.8

1.7

g/l

1.5

0.07

150

1303

(40768443) Skin Pathology biopsy report

134

1106

1.22

1.44

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

137

1134

1.22

1.43

4.5

3.9

mmol/l

24.3

24.9

1.00

114

1018

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.25

1.40

1.4

1.5

ng/l

120.9

109.5

—

(3051651) Icteric interference index of Serum or Plasma

181

1.55

1.40

4.7

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

687

6377

1.10

1.39

2.6

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

432

1.35

1.39

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

187

1598

1.18

1.39

2.7

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.08

1.38

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

182

1.54

1.37

2.4

1.8

—

(21494755) Public health laboratory ask at order entry panel

755

0.75

1.36

1.3

1.4

—

(4281824)

273

0.58

1.35

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.97

1.32

1.0

miu/ml

2161.6

1688.9

0.65

(3012441) Differential panel - Pleural fluid

368

1.36

1.31

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

378

1.35

1.28

28.4

5.7

mmol/l

8.0

7.4

0.40

311

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.09

1.27

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

130

1.62

1.26

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

414

1.33

1.26

1.1

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

751

1.25

1.2

u/ml

0.3

0.6

0.54

(3016650) Hepatitis A virus Ab [Presence] in Serum

286

1.40

1.25

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

152

1779

0.85

1.22

1.3

1.7

1.5

0.98

115

1493

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

380

3453

1.11

1.19

1.3

iu/ml

48.7

39.8

0.34

122

1064

(3001893) Eosinophils/100 leukocytes in Pleural fluid

109

1.66

1.18

1.2

1.6

6.3

2.4

0.38

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

125

1.60

1.17

1.3

1.6

62.3

68.0

0.36

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

165

1.52

1.17

1.0

ng/l

37.1

44.2

0.45

102

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

165

1.52

1.17

1.0

ng/l

523.2

663.7

1.34

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

282

1.39

1.16

3.3

2.3

u/field

3.2

2.1

0.17

(3009214) Lutropin [Units/volume] in Serum or Plasma

308

1.37

1.15

2.0

1.4

u/l

15.9

11.1

0.64

245

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.15

1.4

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

609

0.75

1.13

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

617

1.25

1.13

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

292

1.37

1.13

1.4

1.5

54.8

62.6

0.51

195

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

258

1.40

1.13

1.1

1.2

u/l

63.8

54.1

0.28

174

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

0.45

1.12

1.2

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.38

1.09

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

160

1.50

1.09

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

531

1.27

1.09

1.8

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

194

0.57

1.09

1.1

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.19

1.08

1.9

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

321

1.34

1.07

1.4

1.3

iu/l

31.6

31.3

0.02

271

(36660697) Celiac disease serology panel - Serum

181

1582

1.15

1.07

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

941

1.20

1.07

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

324

2940

1.11

1.06

3.3

3.2

ng/l

302.8

252.1

0.97

291

2689

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

714

1.22

1.05

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

921

0.81

1.03

1.8

—

(3027008) Opiates [Presence] in Urine

276

0.65

1.03

1.3

2.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.03

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.06

1.03

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

536

1.26

1.02

1.6

2.3

umol/l

32.3

31.9

0.03

434

(3023199) Leukocytes [#/volume] in Pleural fluid

421

1.29

1.01

1.6

1.5

e6/l

1480.4

2024.7

0.41

302

(3028308) Erythrocytes [#/volume] in Pleural fluid

386

1.30

1.01

1.6

1.5

e6/l

33412.6

46689.0

0.42

234

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

164

1.47

0.99

1.0

ng/l

295.5

315.6

0.19

103

(3027944) Amphetamines [Presence] in Urine

273

0.66

0.99

1.3

2.0

—

(3019977) pH of Arterial blood

181

1.44

0.98

2.7

2.5

7.4

0.66

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

621

1.23

0.97

1.4

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

173

1.45

0.97

2.7

2.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

301

1.33

0.97

1.4

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

165

1.46

0.96

1.6

1.5

u/l

1.7

7.5

2.85

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.95

0.0

1.2

—

(4035726)

246

2215

1.12

0.95

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.65

0.94

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.78

0.94

1.2

1.3

—

(4133840)

1.89

0.94

1.6

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

338

1.31

0.93

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

780

1.20

0.93

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

309

2822

1.11

0.92

2.3

2.5

ug/l

7.6

6.6

0.22

246

2347

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.67

0.91

1.6

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

118

1.53

0.90

1.8

1.6

nmol/l

13.6

16.8

1.21

104

(3004616) Nuclear Ab [Presence] in Serum

270

1.34

0.90

1.1

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

402

1.27

0.90

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

255

0.66

0.90

1.2

1.6

—

(3021788) Differential panel - Synovial fluid

465

1.25

0.90

1.5

—

(40761535) Cells panel - Urine sediment

212

2360

0.89

5.0

3.7

—

(3011288) Drugs identified in Urine by Screen method

182

0.60

0.89

1.5

3.0

—

(1002224) Polysomnography panel

502

1.24

0.88

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

277

0.68

0.88

1.4

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

211

1893

1.12

0.88

5.8

6.1

mmol/l

24.4

24.6

0.38

191

1766

(3002619) Bacteria identified in Specimen by Culture

1.79

0.87

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

298

1.31

0.87

1.4

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

722

1.20

0.87

1.1

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

178

1.41

0.86

1.6

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.82

0.85

1.3

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

275

0.69

0.85

1.3

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.67

0.85

1.2

1.6

ug/l

0.3

0.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.94

0.84

1.2

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

224

2024

1.11

0.83

1.4

1.6

—

(3020650) Glucose [Presence] in Urine

1.76

0.83

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.76

0.83

1.2

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

107

920

1.17

0.83

4.4

4.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

308

0.71

0.83

3.0

2.0

u/ml

63.7

995.6

0.56

299

(42529406) Shigella sp [Presence] in Stool by Culture

726

1.19

0.83

1.1

1.2

—

(4094501)

567

0.79

0.82

1.0

1.1

—

(4212803)

1.88

0.81

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.61

0.81

11.3

6.2

mmol/l

25.1

24.8

0.12

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

454

0.77

0.81

1.4

1.3

—

(3035880) pH of Pleural fluid

198

1.37

0.80

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

107

924

1.16

0.80

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

259

0.69

0.79

1.3

2.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.79

0.0

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

583

1.21

0.79

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

173

1.39

0.78

18.3

16.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

394

1.25

0.77

2.8

2.2

mg/l

24.4

23.1

0.07

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

217

1.34

0.76

1.1

1.2

mmol/l

7.7

0.00

144

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

273

2507

1.10

0.76

1.9

2.0

g/l

0.2

0.13

253

2305

(3034891) Synovial lining cells/100 cells in Synovial fluid

107

1.50

0.76

1.1

1.4

4.4

2.4

—

(3014891) Appearance of Pleural fluid

1.70

0.75

1.6

1.5

—

(4015189)

1.60

0.74

2.6

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

450

1.23

0.74

1.2

1.3

e6/l

72.5

29.0

0.26

354

(3020491) Glucose [Moles/volume] in Blood

175

1.37

0.74

1.6

2.8

mmol/l

7.6

7.0

0.30

122

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.74

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.74

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.74

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.74

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.84

0.73

48.6

7.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

307

1.27

0.73

4.9

3.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

451

1.22

0.73

1.2

1.3

e6/l

62.0

616.6

1.55

370

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.64

0.73

1.0

100.9

96.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

108

1.48

0.73

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

108

1.48

0.73

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

135

0.59

0.73

1.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

135

0.59

0.73

1.0

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

135

0.59

0.73

1.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

135

0.59

0.73

1.0

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

498

1.21

0.71

1.4

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

145

1292

1.13

0.71

2.0

—

(3049717) Cytology report of Urine Cyto stain

128

1133

1.14

0.70

3.0

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

472

1.21

0.70

1.3

1.2

u/l

35.6

45.4

0.33

405

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.71

0.70

1.4

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

142

0.63

0.69

1.1

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.67

0.68

1.3

1.7

—

(3006270) Folate [Moles/volume] in Blood

266

1.28

0.68

1.3

1.2

nmol/l

414.8

322.0

1.88

209

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

240

1.29

0.67

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

134

1194

1.13

0.67

2.0

1.9

—

(3023410) Appearance of Cerebral spinal fluid

197

1.32

0.65

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

175

1588

1.11

0.64

3.8

4.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.48

0.64

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.73

0.64

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.60

0.61

1.0

1.8

ug/l

3.9

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3034426) Prothrombin time (PT)

1.54

0.59

1.1

1.3

—

(4268621)

166

1.33

0.58

2.4

2.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

2.2

—

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

115

1.39

0.56

1.1

—

(40757373) Influenza virus identified in Isolate

0.57

0.56

3.0

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.54

0.55

1.6

1.1

—

(40768441) Liver Pathology biopsy report

148

0.67

0.55

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

177

1.30

0.54

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

126

0.63

0.54

1.0

1.4

—

(3042631) Mycobacterium sp identified in Specimen

395

1.19

0.53

2.6

2.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

525

1.17

0.53

1.1

1.2

u/ml

2.5

8.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.50

0.51

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

135

1.34

0.51

2.7

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

347

0.81

0.50

1.4

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.39

0.50

2.2

2.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

144

1.32

0.50

2.4

1.9

66.1

70.8

0.44

131

(3037121) Protein [Mass/volume] in Urine

110

991

1.11

0.50

3.3

2.8

g/l

0.3

0.16

364

(3005570) Glucose [Moles/volume] in Urine

297

1.21

0.50

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

1.36

0.50

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

127

1.34

0.49

1.2

u/ml

0.4

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.56

0.49

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.52

0.48

1.7

1.4

—

(44813793)

128

1.33

0.47

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.49

0.47

1.3

—

(4211845)

137

1.32

0.47

4.3

4.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.46

0.46

48.7

7.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.43

0.45

1.8

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.40

0.45

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

164

0.73

0.45

1.0

1.1

u/ml

0.3

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

165

1.27

0.45

1.8

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

165

1.27

0.45

1.8

1.3

—

(4146454)

320

1.19

0.44

2.8

2.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

311

1.19

0.44

2.9

4.0

umol/l

357.8

345.5

0.19

260

(3014051) Protein [Presence] in Urine by Test strip

620

1.13

0.44

2.3

—

(3045788) Cell count panel - Pleural fluid

330

1.18

0.44

1.7

1.5

—

(3006462) Nitrate [Presence] in Urine

130

1.31

0.44

4.4

4.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

229

1.22

0.43

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

571

5503

1.05

0.43

5.4

4.9

kg/l

1.0

0.64

108

890

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

139

1.30

0.43

2.3

2.0

9.0

16.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

104

1.35

0.43

1.4

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

104

1.35

0.43

1.4

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

285

1.20

0.42

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

221

1.22

0.42

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

313

1.18

0.42

3.7

4.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

131

1.30

0.42

1.0

1.1

u/l

87.2

79.5

0.24

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

131

1.30

0.42

1.0

1.1

u/l

16.5

26.1

—

(3022313) Gas panel - Capillary blood

144

1331

1.09

0.42

4.4

3.7

—

(3025130) Human papilloma virus identified in Specimen

149

1.28

0.41

1.9

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

305

0.82

0.41

1.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.52

0.41

1.2

g/l

8.2

16.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

29.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

114

1.32

0.40

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

333

1.17

0.40

3.4

3.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

259

1.20

0.40

1.2

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.40

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.33

0.40

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

177

1.24

0.40

2.0

1.9

ug/l

2.2

1.9

0.47

149

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

380

1.16

0.40

1.5

1.8

—

(3017569) Oxygen content in Arterial blood

159

1.26

0.40

1.8

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

102

0.69

0.39

1.9

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.43

0.39

1.0

1.3

nmol/l

3.7

5.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

148

0.74

0.38

4.6

3.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

151

1.26

0.38

1.9

2.0

u/field

3.0

2.7

0.06

101

(3044242) Glucose [Moles/volume] in Arterial blood

181

0.77

0.38

1.9

2.0

—

(3003694) ABO and Rh group [Type] in Blood

592

5731

1.04

0.38

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.35

0.38

1.3

1.2

—

(3022621) pH of Urine by Test strip

197

1853

1.07

0.37

4.1

3.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

124

1146

1.09

0.37

1.2

iu/ml

88.5

126.8

0.95

400

(3047352) Trisomy 18 risk [Likelihood] in Fetus

112

0.71

0.37

1.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

112

0.71

0.37

1.0

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

1.31

0.37

1.4

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.31

0.37

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

114

0.70

0.37

1.0

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

1.28

0.37

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.27

0.36

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

134

1.27

0.36

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.27

0.36

1.4

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

516

1.13

0.36

1.1

1.2

u/ml

7.9

4.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

153

1429

1.07

0.36

4.5

2.3

0.7

0.21

147

1374

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

384

1.15

0.36

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

135

0.74

0.36

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.27

0.36

2.0

2.7

176.7

185.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.43

0.35

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

153

1.24

0.35

1.7

2.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.26

0.35

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.26

0.35

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.26

0.35

1.4

1.1

—

(3024263) Appearance of Synovial fluid

156

0.77

0.34

1.3

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

181

1.22

0.34

1.7

1.9

ug/l

3.8

3.1

0.28

162

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.36

0.34

1.8

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

218

1.19

0.34

1.4

1.3

—

(3016228) CD19 cells/100 cells in Blood

1.34

0.34

2.0

7.0

7.7

0.10

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.30

0.33

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

0.70

0.33

5.2

2.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

169

1593

1.06

0.32

4.8

3.2

mmol/l

24.6

25.2

1.10

160

1553

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

220

1.18

0.31

1.0

u/ml

0.8

2.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

230

0.83

0.31

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

230

0.83

0.31

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

230

0.83

0.31

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

219

0.82

0.31

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

294

0.85

0.31

3.2

3.7

61.9

57.1

0.67

179

(3048879) Bone marrow aspiration report

0.71

0.30

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

218

0.82

0.30

1.3

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

102

1.28

0.30

1.0

u/ml

2.8

2.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

196

0.82

0.30

2.9

2.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.29

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.23

0.29

2.0

1.3

umol/l

2.3

2.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

151

0.79

0.28

1.5

1.6

—

72.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

280

1.14

0.27

1.1

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.25

0.27

3.0

1.9

9.4

8.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.25

0.27

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

854

0.92

0.27

1.5

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

701

1.09

0.27

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.23

0.27

3.0

1.9

28.0

28.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

309

1.13

0.27

1.1

iu/ml

11.5

77.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.67

0.25

5.8

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

197

1.17

0.25

1.1

—

41.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

186

1945

0.95

0.24

2.5

2.9

ml/min/173m2

56.6

59.1

0.35

900

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

337

3264

1.04

0.24

4.9

4.7

33.5

33.7

0.12

211

2075

(3044941) Cell count panel - Synovial fluid

436

1.10

0.24

1.4

—

(3019225) pH of Specimen

306

2962

1.04

0.23

5.6

4.7

—

(3028707) Methadone [Presence] in Urine by Screen method

136

0.81

0.23

1.5

2.7

—

(3014271) Vancomycin [Susceptibility]

228

1.14

0.22

4.8

3.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.27

0.22

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

652

1.08

0.21

1.5

1.6

e6/l

9170.2

17411.3

2.20

470

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

339

3294

1.03

0.21

1.2

u/ml

26.8

14.9

1.12

103

1135

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(44806071)

0.00

0.20

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.20

0.0

2.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

9.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

5.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.25

0.20

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

187

0.85

0.20

1.1

u/ml

0.4

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

108

1.20

0.20

1.0

u/ml

2.0

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.22

0.20

1.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

471

1.08

0.19

3.9

1.9

1.5

0.17

353

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

197

0.86

0.19

1.2

1.4

—

63.2

—

(44806420)

118

1.19

0.19

2.1

2.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

1.19

0.16

1.1

—

(44806118)

263

1.10

0.16

1.5

1.4

—

(44790049)

263

1.10

0.16

1.5

1.4

—

(44790047)

263

1.10

0.16

1.5

1.4

—

(44790048)

263

1.10

0.16

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

152

1465

1.04

0.16

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

120

1.17

0.16

1.4

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

139

1.15

0.16

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

139

1.15

0.16

1.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

139

1.15

0.16

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

139

1.15

0.16

1.4

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

254

1.10

0.16

1.2

e6/l

9351.7

149051.3

2.16

169

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.76

0.15

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.76

0.15

1.2

2.0

ug/l

19.8

117.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

245

1.10

0.15

1.2

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

121

1.16

0.15

1.4

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.08

0.14

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

522

0.94

0.14

1.5

1.7

mg/l

5.7

3.8

0.38

411

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

141

1.14

0.14

1.1

1.3

—

(21494434) Karyotype in Bone marrow

257

1.09

0.13

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

307

3133

0.98

0.13

3.5

3.7

ug/l

22.5

23.9

0.04

251

2592

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

599

1.05

0.12

1.2

—

(40768793) Breast Pathology biopsy report

570

0.95

0.12

1.1

1.4

—

(4010399)

167

1716

0.97

0.12

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

772

0.96

0.11

1.5

1.8

—

(3045142) Bone marrow Pathology biopsy report

298

1.07

0.11

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

178

0.90

0.11

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

126

0.87

0.11

2.6

2.5

46.2

39.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

484

1.05

0.11

2.9

2.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.16

0.11

1.3

1.2

g/l

—

0.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

231

1.08

0.10

1.1

1.4

36.6

28.5

0.35

150

(3003740) Influenza virus B Ag [Presence] in Specimen

177

0.90

0.10

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

212

1.09

0.10

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.06

0.09

2.6

2.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.15

0.09

1.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

116

1.12

0.09

1.6

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.09

3.8

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.09

3.8

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

498

1.04

0.08

1.8

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

247

0.93

0.08

2.3

1.6

u/ml

17.6

23.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.07

0.08

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

1.07

0.08

1.0

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.05

0.08

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.83

0.08

1.2

1.5

ug/l

9.5

9.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.81

0.08

1.8

1.6

iu/ml

—

2024630.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

133

0.90

0.07

1.4

1.2

mmol/l

9.6

11.6

—

(3044007) Cell count panel - Peritoneal fluid

0.80

0.07

3.8

1.9

—

(40765096) Chromosome analysis panel by Banding

1.03

0.07

1.5

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.07

0.07

1.0

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

157

1.08

0.07

1.0

1.1

—

(3020891) Body temperature

118

1205

0.98

0.06

5.9

4.1

—

(3023419) Bacteria identified in Sputum by Culture

354

1.05

0.06

1.8

2.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

264

0.95

0.06

1.7

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

109

1.10

0.06

1.2

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

217

1.06

0.06

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

343

3456

0.99

0.04

9.8

8.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

160

1.06

0.04

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

160

1.06

0.04

1.5

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

101

1.09

0.04

1.0

1.2

nmol/l

132.2

138.6

0.24

101

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

114

1157

0.98

0.04

2.9

3.8

u/ml

241.2

74.1

0.68

108

1114

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

129

0.93

0.03

5.4

6.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

1.07

0.03

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

649

1.02

0.02

3.8

mg/l

31.8

28.2

0.41

433

(4024509)

309

0.97

0.02

1.7

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

103

1041

0.99

0.02

2.7

3.0

u/ml

1866.7

2541.6

0.17

873

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

248

0.97

0.02

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.08

0.02

1.1

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

529

0.98

0.02

1.3

1.2

titre

73.3

90.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

103

1.07

0.02

5.5

4.2

59.0

55.0

0.18

(44816559) Phosphatidylethanol [Mass/volume] in Blood

308

0.97

0.02

1.0

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

451

4497

1.00

0.01

31.5

30.6

inr

1.5

0.07

602

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

939

0.99

0.01

1.3

—

(40768800) Prostate Pathology biopsy report

508

0.98

0.01

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

237

0.97

0.01

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

194

1.03

0.00

1.4

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

356

0.98

0.00

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

356

0.98

0.00

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

252

2514

1.00

0.00

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

131

0.99

0.00

1.0

u/ml

0.5

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

355

0.99

0.00

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

219

1.00

0.00

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

229

1.00

0.00

1.2

—

(3044927) Protein electrophoresis panel - Urine

351

1.00

0.00

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

479

1.00

0.00

1.6

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

166

1.02

0.00

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

354

0.99

0.00

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

354

0.99

0.00

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

353

0.99

0.00

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

103

0.97

0.00

1.3

1.2

—

(3017704) Immunofixation for Urine

177

1.02

0.00

1.1

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

157

1.02

0.00

3.4

3.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.93

0.00

1.4

1.1

140.2

104.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

294.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

150

1.00

0.00

1.3

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

920

1.00

0.00

3.3

nmol/l

0.8

1.41

686

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.00

0.00

2.7

2.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.00

0.00

1.4

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.1

—

19.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

12.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.00

0.00

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.02

0.00

1.0

1.5

g/l

39.1

27.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.94

0.00

1.2

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.9

—

4.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.02

0.00

1.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

2.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.95

0.00

1.4

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

7.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.86

0.00

1.2

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCOMAMEDICATION and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_GLAUCOMAMEDICATION	0.897 [0.84, 0.96]	0.002
Birth year	0.99 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 5847 out of 15112 females with H7_GLAUCOMAMEDICATION died.

Males

Parameter	HR [95% CI]	p-value
H7_GLAUCOMAMEDICATION	0.969 [0.89, 1.06]	0.483
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 3519 out of 9395 males with H7_GLAUCOMAMEDICATION died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCOMAMEDICATION.

N-year risk	Females	Males
1	0.089%	0.153%
5	0.487%	1.08%
10	1.161%	2.555%
15	2.208%	5.031%
20	3.784%	8.639%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCOMAMEDICATION – Use of antiglaucoma preparations and miotics

GWS hits: 11

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Use of antiglaucoma preparations and miotics

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints